View Financial HealthCosnine 배당 및 자사주 매입배당 기준 점검 0/6Cosnine 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률0%자사주 매입 수익률총 주주 수익률0%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공지 • Mar 17Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2026Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 27, hagunsandan 2-ro, yangchon-eup, gyeonggi-do, gimpo South Korea공지 • Mar 18Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2025Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 27, hagunsandan 2-ro, yangchon-eup, gyeonggi-do, gimpo South Korea분석 기사 • Mar 22Is Cosnine (KOSDAQ:082660) Using Debt In A Risky Way?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...공지 • Aug 01Cosnine Co., Ltd. announced that it has received KRW 4 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment ArmOn July 31, 2023, Cosnine Co., Ltd. closed the transaction.Board Change • Mar 13No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Apr 08Full year 2021 earnings released: ₩242 loss per share (vs ₩443 loss in FY 2020)Full year 2021 results: ₩242 loss per share (up from ₩443 loss in FY 2020). Revenue: ₩12.5b (down 40% from FY 2020). Net loss: ₩9.56b (loss narrowed 7.2% from FY 2020). Over the last 3 years on average, earnings per share has increased by 127% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 17Third quarter 2021 earnings released: ₩9.61 loss per share (vs ₩39.00 loss in 3Q 2020)The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: ₩2.75b (down 16% from 3Q 2020). Net loss: ₩392.5m (loss narrowed 54% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.공지 • Feb 26Cosnine Co., Ltd. announced that it has received KRW 6.0116 billion in funding from Icure Pharmaceutical IncorporationOn February 25, 2021, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.공지 • Feb 11Cosnine Co., Ltd. announced that it expects to receive KRW 6.0116 billion in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 4,520,000 common share at an issue price of KRW 1,330 per share for gross proceeds of KRW 6,011,600,000 on February 10, 2021. The face value of the shares to be issued is KRW 500 per share. The company will raise funds through third party allocation method. The shares to be issued will have a hold period of one year, post the closing. The payment date is on February 25, 2021. The transaction has been approved by the board of directors of the company.Is New 90 Day High Low • Jan 18New 90-day low: ₩1,460The company is down 11% from its price of ₩1,640 on 20 October 2020. The South Korean market is up 30% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 45% over the same period.공지 • Dec 04Cosnine Co., Ltd. announced that it has received KRW 4 billion in funding from Icure Pharmaceutical IncorporationOn December 3, 2020, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.공지 • Nov 05Cosnine Co., Ltd. announced that it expects to receive KRW 4 billion in funding from Icure Pharmaceutical Incorporation and another investorCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of series 20 unregistered coupon non-guaranteed private convertible bonds for gross proceeds of KRW 4,000,000,000 on November 03, 2020. The transaction will include participation from Icure Pharmaceutical Incorporation (KOSDAQ:A175250) and Trevia Inc. for KRW 2,000,000,000. The bonds do not carry any coupon and yield to maturity of 4% and will mature on November 30, 2023. The bonds are 100% convertible into 2,461,538 common shares representing 8.70% of the total number of shares of the company at a conversion price of KRW 1,625 per share. The conversion period of the bonds will start on November 30, 2021 and ends on October 30, 2023. The subscription date and the payment date are on November 3, 2020 and November 30, 2020. The transaction has been approved by the board of directors of the company.공지 • Sep 30Cosnine Co., Ltd. announced that it has received KRW 4.99954 billion in fundingOn September 29, 2020, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.공지 • Sep 26Cosnine Co., Ltd. announced that it expects to receive KRW 999.99879 million in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 709,219 common shares at a price of KRW 1,410 per share for the gross proceeds of KRW 999,998,790 on September 25, 2020. The transaction will include participation from Bioline Value Investment Fund. The shares issued in the transaction have a par value of KRW 500 per share. The security will be issued at premium of 10%. The transaction will take place through third party allotment. The securities are subject to a hold period of 1 year. The transaction was approved by the board of directors of the company. The transaction is expected to close on October 8, 2020.Is New 90 Day High Low • Sep 22New 90-day high: ₩1,630The company is up 17% from its price of ₩1,395 on 24 June 2020. The South Korean market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 14% over the same period.공지 • Sep 22Cosnine Co., Ltd. announced that it expects to receive KRW 4.99954 billion in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 3,731,000 common shares at a price of KRW 1,340 per share for the gross proceeds of KRW 4,999,540,000 on September 21, 2020. The transaction will include participation from Bioline Value Investment Fund. The shares issued in the transaction have a par value of KRW 500 per share. The security will be issued at premium of 10%. The transaction will take place through third party allotment. The securities are subject to a hold period of 1 year. The transaction was approved by the board of directors of the company. The transaction is expected to close on September 29, 2020.공지 • Sep 11Cosnine Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99985 million.Cosnine Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99985 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 778,210 Price\Range: KRW 1285 Transaction Features: Subsequent Direct Listing공지 • Aug 15Cosnine Co., Ltd. announced that it expects to receive KRW 2 billion in funding from Sangsangin Savings Bank, Investment ArmCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of series 19 registered non-guaranteed private convertible bonds for gross proceeds of KRW 2,000,000,000 on August 14, 2020. The bonds carry a coupon rate of 5% and interest rate to maturity of 7% and will mature on August 18, 2023. The bonds are 100% convertible into 1,594,896 common shares representing 7.45% of the total number of shares of the company at a conversion price of KRW 1,254 per share. The conversion period of the bonds will start on August 18, 2021 and ends on July 18, 2023. The transaction will include participation from returning investor Sangsangin Savings Bank, Investment Arm. The transaction has been approved by the board of directors of the company. The subscription date of the transaction is on the same day and the payment date is on August 18, 2020.공지 • Jul 17+ 1 more updateCosnine Co., Ltd. announced that it expects to receive KRW 2 billion in fundingCosnine Co., Ltd (KOSDAQ:A082660) announced a private placement to issue series 18 bearer mortgage convertible bond of KRW 2,000,000,000 on July 9, 2020. The transaction will include participation from Markers Investment Co., Ltd. for KRW 1,000,000,000, Jo Sung Woo and Dohyung Lim for KRW 300,000,000 each, and Dongik Kim for KRW 400,000,000. The bonds will carry rate of interest of 4% and will mature on July 10, 2023. The bonds are convertible into 1,543,209 common shares of the company at a conversion price of KRW 1,296 per share. The conversion period will start at July 10, 2021 and ends on June 10, 2023. The transaction is expected to close on July 10, 2020. The transaction has been approved by the board of directors of the company.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 A082660 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: A082660 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Cosnine 배당 수익률 vs 시장A082660의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (A082660)n/a시장 하위 25% (KR)0.9%시장 상위 25% (KR)3.5%업계 평균 (Electronic)0.5%분석가 예측 (A082660) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 A082660 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 A082660 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 A082660 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: A082660 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YKR 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/11/03 01:17종가2024/08/07 00:00수익2024/06/30연간 수익2023/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Cosnine Co., Ltd.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Mina LeeiM Securities
공지 • Mar 17Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2026Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 27, hagunsandan 2-ro, yangchon-eup, gyeonggi-do, gimpo South Korea
공지 • Mar 18Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2025Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 27, hagunsandan 2-ro, yangchon-eup, gyeonggi-do, gimpo South Korea
분석 기사 • Mar 22Is Cosnine (KOSDAQ:082660) Using Debt In A Risky Way?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
공지 • Aug 01Cosnine Co., Ltd. announced that it has received KRW 4 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment ArmOn July 31, 2023, Cosnine Co., Ltd. closed the transaction.
Board Change • Mar 13No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Apr 08Full year 2021 earnings released: ₩242 loss per share (vs ₩443 loss in FY 2020)Full year 2021 results: ₩242 loss per share (up from ₩443 loss in FY 2020). Revenue: ₩12.5b (down 40% from FY 2020). Net loss: ₩9.56b (loss narrowed 7.2% from FY 2020). Over the last 3 years on average, earnings per share has increased by 127% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 17Third quarter 2021 earnings released: ₩9.61 loss per share (vs ₩39.00 loss in 3Q 2020)The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: ₩2.75b (down 16% from 3Q 2020). Net loss: ₩392.5m (loss narrowed 54% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.
공지 • Feb 26Cosnine Co., Ltd. announced that it has received KRW 6.0116 billion in funding from Icure Pharmaceutical IncorporationOn February 25, 2021, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.
공지 • Feb 11Cosnine Co., Ltd. announced that it expects to receive KRW 6.0116 billion in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 4,520,000 common share at an issue price of KRW 1,330 per share for gross proceeds of KRW 6,011,600,000 on February 10, 2021. The face value of the shares to be issued is KRW 500 per share. The company will raise funds through third party allocation method. The shares to be issued will have a hold period of one year, post the closing. The payment date is on February 25, 2021. The transaction has been approved by the board of directors of the company.
Is New 90 Day High Low • Jan 18New 90-day low: ₩1,460The company is down 11% from its price of ₩1,640 on 20 October 2020. The South Korean market is up 30% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 45% over the same period.
공지 • Dec 04Cosnine Co., Ltd. announced that it has received KRW 4 billion in funding from Icure Pharmaceutical IncorporationOn December 3, 2020, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.
공지 • Nov 05Cosnine Co., Ltd. announced that it expects to receive KRW 4 billion in funding from Icure Pharmaceutical Incorporation and another investorCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of series 20 unregistered coupon non-guaranteed private convertible bonds for gross proceeds of KRW 4,000,000,000 on November 03, 2020. The transaction will include participation from Icure Pharmaceutical Incorporation (KOSDAQ:A175250) and Trevia Inc. for KRW 2,000,000,000. The bonds do not carry any coupon and yield to maturity of 4% and will mature on November 30, 2023. The bonds are 100% convertible into 2,461,538 common shares representing 8.70% of the total number of shares of the company at a conversion price of KRW 1,625 per share. The conversion period of the bonds will start on November 30, 2021 and ends on October 30, 2023. The subscription date and the payment date are on November 3, 2020 and November 30, 2020. The transaction has been approved by the board of directors of the company.
공지 • Sep 30Cosnine Co., Ltd. announced that it has received KRW 4.99954 billion in fundingOn September 29, 2020, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.
공지 • Sep 26Cosnine Co., Ltd. announced that it expects to receive KRW 999.99879 million in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 709,219 common shares at a price of KRW 1,410 per share for the gross proceeds of KRW 999,998,790 on September 25, 2020. The transaction will include participation from Bioline Value Investment Fund. The shares issued in the transaction have a par value of KRW 500 per share. The security will be issued at premium of 10%. The transaction will take place through third party allotment. The securities are subject to a hold period of 1 year. The transaction was approved by the board of directors of the company. The transaction is expected to close on October 8, 2020.
Is New 90 Day High Low • Sep 22New 90-day high: ₩1,630The company is up 17% from its price of ₩1,395 on 24 June 2020. The South Korean market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 14% over the same period.
공지 • Sep 22Cosnine Co., Ltd. announced that it expects to receive KRW 4.99954 billion in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 3,731,000 common shares at a price of KRW 1,340 per share for the gross proceeds of KRW 4,999,540,000 on September 21, 2020. The transaction will include participation from Bioline Value Investment Fund. The shares issued in the transaction have a par value of KRW 500 per share. The security will be issued at premium of 10%. The transaction will take place through third party allotment. The securities are subject to a hold period of 1 year. The transaction was approved by the board of directors of the company. The transaction is expected to close on September 29, 2020.
공지 • Sep 11Cosnine Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99985 million.Cosnine Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99985 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 778,210 Price\Range: KRW 1285 Transaction Features: Subsequent Direct Listing
공지 • Aug 15Cosnine Co., Ltd. announced that it expects to receive KRW 2 billion in funding from Sangsangin Savings Bank, Investment ArmCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of series 19 registered non-guaranteed private convertible bonds for gross proceeds of KRW 2,000,000,000 on August 14, 2020. The bonds carry a coupon rate of 5% and interest rate to maturity of 7% and will mature on August 18, 2023. The bonds are 100% convertible into 1,594,896 common shares representing 7.45% of the total number of shares of the company at a conversion price of KRW 1,254 per share. The conversion period of the bonds will start on August 18, 2021 and ends on July 18, 2023. The transaction will include participation from returning investor Sangsangin Savings Bank, Investment Arm. The transaction has been approved by the board of directors of the company. The subscription date of the transaction is on the same day and the payment date is on August 18, 2020.
공지 • Jul 17+ 1 more updateCosnine Co., Ltd. announced that it expects to receive KRW 2 billion in fundingCosnine Co., Ltd (KOSDAQ:A082660) announced a private placement to issue series 18 bearer mortgage convertible bond of KRW 2,000,000,000 on July 9, 2020. The transaction will include participation from Markers Investment Co., Ltd. for KRW 1,000,000,000, Jo Sung Woo and Dohyung Lim for KRW 300,000,000 each, and Dongik Kim for KRW 400,000,000. The bonds will carry rate of interest of 4% and will mature on July 10, 2023. The bonds are convertible into 1,543,209 common shares of the company at a conversion price of KRW 1,296 per share. The conversion period will start at July 10, 2021 and ends on June 10, 2023. The transaction is expected to close on July 10, 2020. The transaction has been approved by the board of directors of the company.